Three more biotechs hit Nas­daq as the sec­tor, now with more than $13B raised, con­tin­ues bar­rel­ing to­ward record

Ed­i­tor’s note: In­ter­est­ed in fol­low­ing bio­phar­ma’s fast-paced IPO mar­ket? You can book­mark our IPO Track­er here.

Af­ter a sum­mer slum­ber, the biotech IPO mar­ket is back in full swing with three new pric­ings drop­ping Wednes­day and two SPACs en­ter­ing the ring.

DiCE Ther­a­peu­tics and Tyra Bio­sciences each hit Nas­daq on Wednes­day with nine-fig­ure rais­es, while small-cap Pa­sithea Ther­a­peu­tics al­so de­buted with a $24 mil­lion raise. The pric­ings have pushed the com­bined in­dus­try raise north of $13 bil­lion so far in 2021, per the End­points News track­er, a fig­ure like­ly to eclipse last year’s record to­tal of $16.5 bil­lion.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.